These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30808564)

  • 21. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R; Soros A; Jakubowicz S
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
    Liang Y; Wei H; Zhang JL; Hou L; Luo XP
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central precocious puberty: treatment with triptorelin 11.25 mg.
    Chiocca E; Dati E; Baroncelli GI; Cassio A; Wasniewska M; Galluzzi F; Einaudi S; Cappa M; Russo G; Bertelloni S
    ScientificWorldJournal; 2012; 2012():583751. PubMed ID: 22645436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal luteinizing hormone/follicle stimulating hormone ratio in diagnosis of central precocious puberty.
    Supornsilchai V; Hiranrat P; Wacharasindhu S; Srivuthana S; Aroonparkmongkol S
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S145-51. PubMed ID: 12929982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic value of baseline serum luteinizing hormone level for central precocious puberty in girls].
    Ou-Yang LX; Yang F
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul; 19(7):729-733. PubMed ID: 28697822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty.
    Lee HS; Yoon JS; Hwang JS
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):392-398. PubMed ID: 27215137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty.
    Poomthavorn P; Khlairit P; Mahachoklertwattana P
    Horm Res; 2009; 72(2):114-9. PubMed ID: 19690429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced bone age as an indicator facilitates the diagnosis of precocious puberty.
    Xu YQ; Li GM; Li Y
    J Pediatr (Rio J); 2018; 94(1):69-75. PubMed ID: 28866322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in pituitary-gonadal suppression during intranasal buserelin and intramuscular depot-triptorelin therapy for central precocious puberty. Belgian Study Group for Pediatric Endocrinology.
    Heinrichs C; Craen M; Vanderschueren-Lodeweyckx M; Malvaux P; Fawe L; Bourguignon JP
    Acta Paediatr; 1994 Jun; 83(6):627-33. PubMed ID: 7919761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are pre-injection LH levels useful in monitoring treatment?
    Kunz GJ; Sherman TI; Klein KO
    J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1189-98. PubMed ID: 18183790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High diagnostic accuracy of subcutaneous Triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls.
    Freire AV; Escobar ME; Gryngarten MG; Arcari AJ; Ballerini MG; Bergadá I; Ropelato MG
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):398-404. PubMed ID: 22845185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system imaging in girls with central precocious puberty: when is necessary?
    Vuralli D; Gonc EN; Alikasifoglu A; Kandemir N; Ozon ZA
    Arch Endocrinol Metab; 2021 May; 64(5):591-596. PubMed ID: 34033300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group.
    Oostdijk W; Drop SL; Odink RJ; Hümmelink R; Partsch CJ; Sippell WG
    Acta Paediatr Scand Suppl; 1991; 372():39-45; discussion 46. PubMed ID: 1833950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment.
    Adan L; Chemaitilly W; Trivin C; Brauner R
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):297-302. PubMed ID: 11940040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Premature thelarche: identification of clinical and laboratory data for the diagnosis of precocious puberty.
    Della Manna T; Setian N; Damiani D; Kuperman H; Dichtchekenian V
    Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(2):49-54. PubMed ID: 11981584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life.
    Bizzarri C; Spadoni GL; Bottaro G; Montanari G; Giannone G; Cappa M; Cianfarani S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):433-9. PubMed ID: 24297793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.